|
1
|
Yeo JY, Goh GR, Su TTT and Gan SKE: The
determination of HIV-1 RT mutation rate, its possible allosteric
effects, and its implications on drug resistance. Viruses.
12(297)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li JZ, Paredes R, Ribaudo HJ, Svarovskaia
ES, Metzner KJ, Kozal MJ, Hullsiek KH, Balduin M, Jakobsen MR,
Geretti AM, et al: Low-Frequency HIV-1 drug resistance mutations
and risk of NNRTI-Based antiretroviral treatment failure: A
systematic review and pooled analysis. JAMA. 305:1327–1335.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fisicaro V, Campanella E, Marino A,
Guarneri A, Franzò A, Pistarà E, Spampinato S, Bandiera A, Boscia
V, Celesia BM, et al: Laryngeal leishmaniasis in a HIV positive
Patient: A case report and review of the literature. World Acad Sci
J 5: doi:10.3892/WASJ.2023.201, 2023.
|
|
4
|
Soltani S, Farahani A, Zebardast A, Dowran
R, Zandi M, Rafat Z, Sasani E, Zarandi B, Fallahy MP and Didehdar
M: Human immunodeficiency virus and Candida albicans co-infection
in Iran: A systematic review. HIV AIDS Rev. 22:181–188. 2023.
|
|
5
|
Holtz CM and Mansky LM: Variation of HIV-1
mutation spectra among cell types. J Virol. 87:5296–5299.
2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chen R, Yokoyama M, Sato H, Reilly C and
Mansky LM: Human immunodeficiency virus mutagenesis during
antiviral therapy: Impact of drug-resistant reverse transcriptase
and nucleoside and nonnucleoside reverse transcriptase inhibitors
on human immunodeficiency virus type 1 mutation frequencies. J
Virol. 79:12045–12057. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gupta S, Lataillade M, Kyriakides TC,
Chiarella J, John EPS, Webb S, Moreno EA, Simen BB and Kozal MJ:
Low-Frequency NNRTI-resistant HIV-1 variants and relationship to
mutational load in antiretroviral-naïve subjects. Viruses.
6:3428–3437. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Li JZ, Paredes R, Ribaudo HJ, Svarovskaia
ES, Kozal MJ, Hullsiek KH, Miller MD, Bangsberg DR and Kuritzkes
DR: Relationship between minority nonnucleoside reverse
transcriptase inhibitor resistance mutations, adherence, and the
risk of virologic failure. AIDS. 26:185–192. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Paredes R, Lalama CM, Ribaudo HJ,
Schackman BR, Shikuma C, Gigue F, Meyer WA III, Johnson VA, Fiscus
SA, D'Aquila RT, et al: Pre-existing minority drug-resistant HIV-1
variants, adherence, and risk of antiretroviral treatment failure.
J Infect Dis. 201:662–671. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Wensing AM, Calvez V,
Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R,
Shafer RW and Richman DD: 2019 update of the drug resistance
mutations in HIV-1. Top Antivir Med. 27:111–121. 2019.PubMed/NCBI
|
|
11
|
Jiao L, Li H, Li L, Zhuang D, Liu Y, Bao
Z, Liu S and Li J: Impact of novel resistance profiles in HIV-1
reverse transcriptase on phenotypic resistance to NVP. AIDS Res
Treat. 2012(637263)2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
2022 Update of HIV Drug Resistance
Mutations in HIV-1 Is Now Available Online-IAS-USA Available
online: https://www.iasusa.org/2022/09/23/2022-update-of-hiv-drug-resistance-mutations-now-available/
(accessed on 26 December 2023).
|
|
13
|
Wang Z, Zhang M, Wang J, Liu L, Chen J,
Zhang R, Tang Y, Shen Y, Qi T, Song W, et al: Efficacy of
Efavirenz-Based regimen in Antiretroviral-Naïve PAtients with HIV-1
V179D/E mutations in Shanghai, China. Infect Dis Ther. 12:245–255.
2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu Y, Zhang Y, Li H, Wang X, Jia L, Han
J, Li T, Li J and Li L: Natural presence of the V179D and
K103R/V179D mutations associated with resistance to nonnucleoside
reverse transcriptase inhibitors in HIV-1 CRF65_cpx strains. BMC
Infect Dis. 20(313)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Obasa AE, Mikasi SG, Brado D, Cloete R,
Singh K, Neogi U and Jacobs GB: Drug resistance mutations against
protease, reverse transcriptase and integrase inhibitors in people
living with HIV-1 receiving boosted protease inhibitors in South
Africa. Front Microbiol. 11(438)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
SeyedAlinaghi SA, Afsahi AM, Moradi A,
Parmoon Z, Habibi P, Mirzapour P, Dashti M, Ghasemzadeh A, Karimi
E, Sanaati F, et al: Current ART, determinants for virologic
failure and implications for HIV drug resistance: An umbrella
review. AIDS Res Ther. 20(74)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mittelholzer C and Klimkait T: Advances in
molecular genetics enabling studies of highly pathogenic RNA
viruses. Viruses. 14(2682)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Krishnan S, Lippincott CK, Bjerrum S,
Rivera MB and Shah M: A national HIV provider survey of
antiretroviral therapy preferences for management of
treatment-naive and experienced individuals with drug resistance.
Open Forum Infect Dis. 10(ofad541)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Celesia BM, Marino A, Del Vecchio RF,
Bruno R, Palermo F, Gussio M, Nunnari G and Cacopardo B: Is it safe
and cost saving to defer the CD4+ cell count monitoring in stable
patients on ART with more than 350 or 500 cells/ΜL? Mediterr J
Hematol Infect Dis. 11(e2019063)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Marino A, Zafarana G, Ceccarelli M,
Cosentino F, Moscatt V, Bruno G, Bruno R, Benanti F, Cacopardo B
and Celesia BM: Immunological and clinical impact of DAA-mediated
HCV eradication in a cohort of HIV/HCV coinfected patients:
Monocentric Italian experience. Diagnostics (Basel).
11(2336)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Marino A, Caltabiano E, Zagami A, Onorante
A, Zappalà C, Locatelli ME, Pampaloni A, Scuderi D, Bruno R and
Cacopardo B: Rapid emergence of cryptococcal fungemia,
mycobacterium chelonae vertebral osteomyelitis and gastro
intestinal stromal tumor in a young HIV late presenter: A case
report. BMC Infect Dis. 18(693)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Celesia BM, Marino A, Borracino S,
Arcadipane AF, Pantò G, Gussio M, Coniglio S, Pennisi A, Cacopardo
B and Panarello G: Successful extracorporeal membrane oxygenation
treatment in an acquired immune deficiency syndrome (AIDS) patient
with acute respiratory distress syndrome (ARDS) complicating
pneumocystis jirovecii pneumonia: A challenging case. Am J Case
Rep. 21(e919570)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Spampinato S, Saia AG, Russotto Y, Micali
C, Marino A, Ceccarelli M, Rullo E, Pellicanò GF and Nunnari G:
Real-life efficacy and satisfaction of long-acting ART
Cabotegravir-Rilpivirine in HIV-infected individuals. Infectious
Diseases and Tropical Medicine. 9(e1207)2023.
|
|
24
|
Cosentino F, Marino A, Anile L, Moscatt V,
Gussio M, Boscia V, Bruno R, Nunnari G, Pulvirenti A, Privitera GF,
et al: Long-term survivors in a cohort of people living with HIV
diagnosed between 1985 and 1994: Predictive factors associated with
more than 25 years of survival. Infect Dis Rep. 15:70–83.
2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rhee SY, Kassaye SG, Jordan MR, Kouamou V,
Katzenstein D and Shafer RW: Public availability of HIV-1 drug
resistance sequence and treatment data: A systematic review. Lancet
Microbe. 3:e392–e398. 2022.PubMed/NCBI View Article : Google Scholar
|
